Biotechnology

MiMedX Group Corporate Office

MiMedX was founded in 2008 by Parker Petit. The company is a biomedical corporation that uses tissues from birth such as the placenta, amniotic sac, and umbilical cord, to create skin for skin grafts.

In August 2018, CEO Petit listed had his $15 million mansion in the Florida Panhandle for sale. The New York Post called him “the Trump of Georgia”. Petit is a top Republican fundraiser in Georgia, as well as being the finance chair for Trump’s 2016 campaign.

In May 2019, Timothy Wright had been named as CEO.

By August 2019, 13 of 16 executives were no longer with MiMedx. The company stated that Petit, Taylor, Senken, and former Controller John Cranston had ordered the installation of a secret video surveillance system to expose and undermine whistleblowers, called Project Snow White.

They also stated the four had “repeatedly misled or withheld information” from auditors, including Petit in a sworn deposition and Senken in a letter to the SEC. They stated Petit and Taylor “purposely took action to disregard revenue-recognition rules”

On April 6, 2020, MiMedx settled a DOJ lawsuit regarding MiMedx charging inflated prices to the VA Department. The company agreed to pay $6.5 million to settle the suit, which was uncovered through whistleblowers.

MiMedx’s application to relist its common stock on the NASDAQ was approved on October 30, 2020.

In June 2021, the company announced that it would soon release new drugs that would improve treatment methods for tendonitis.

MiMedX maintains a corporate office in Marietta, Georgia.

MiMedX Group

In May 2019, Timothy Wright had been named as CEO.

History

MiMedx’s application to relist its common stock on the NASDAQ was approved on October 30, 2020.

In June 2021, the company announced that it would soon release new drugs that would improve treatment methods for tendonitis.

MiMedX maintains a corporate office in Marietta, Georgia.

BASF Corporate Office

BASF can trace its roots back to 1865 when Friedrich Engelhorn started producing electricity and natural gas for the town of Mannheim in German-speaking Baden. BASF is the initials for Badische Anilin und Soda Fabrik (Badin Anilin and Soda Factory in English). Tar was a natural by-product of the natural gas process, which Engelhorn used to make dyes. BASF was created for the production of chemicals needed to create the dyes.

On 28 July 1948, an explosion occurred at a BASF site in Ludwigshafen, killing 207 people and injuring 3818. In the 1950s, BASF added synthetics such as nylon to its product range. The company had already developed polystyrene in the 1930s and invented Styropor in 1951.

Today, BASF is the largest chemical producer in the world, with subsidiaries and joint ventures in at least 80 countries, and customers in more than 190 countries. Despite its size, the company receives very little attention since it stopped manufacturing and producing products with the BASF name or logo.

In July 2019, the company announced that there would be a lower profit margin for stockholders due to slowing markets from cars to crops and the impact of the U.S.-China trade war.

In November 2019, Lone Star Funds was reportedly having exclusive talks with BASF about possibly acquiring the company’s construction chemical division.

Headquarters for the North American division of BASF are located in Florham Park, New Jersey.

BASF

History

In July 2019, the company announced that there would be a lower profit margin for stockholders due to slowing markets from cars to crops and the impact of the U.S.-China trade war.

In November 2019, Lone Star Funds was reportedly having exclusive talks with BASF about possibly acquiring the company’s construction chemical division.

Headquarters for the North American division of BASF are located in Florham Park, New Jersey.

BioPet Labs Corporate Office

Tom Boyd founded BioPet Labs in 2008. Boyd says he was fascinated by DNA technology but wanted to find a new way to use it. BioPet Labs has two divisions, PooPrints, and BioPet DNA.

Both divisions provide similar services. With more than 40% of people not picking up their dog’s “business”, apartment managers or HOA board members can send samples and BioPet Labs will help to identify the culprit. Cost is $70, but dog owners end up footing the bill when their dog is identified as the guilty party.

BioPet DNA testing goes beyond telling owners exactly what breed(s) their dog is/are, but identifies possible health problems that might develop. Dog breeders can assure their customers that puppies are 100% purebred by using this service.

In 2017, BioPet raked in $7 million. Headquarters are located in Knoxville, Tennessee.

BioPet Labs

Tom Boyd founded BioPet Labs in 2008. Boyd says he was fascinated by DNA technology but wanted to find a new way to use it. BioPet Labs has two divisions, PooPrints, and BioPet DNA.

History

In 2017, BioPet raked in $7 million. Headquarters are located in Knoxville, Tennessee.

23AndMe Coporate Office

In 2006, Paul Cusenza, Linda Avey, and Anne Wojcicki, worked together to build a new company that would provide genetic testing and interpretation of those results. At the time, Wojcicki was married to Google co-founder Sergy Brin. Google invested $3.9 million in the company.

The company offered a new genetic testing service which not only allowed the discernment of ancestry-related results but also offered risk assessment for possible health-related problems due to one’s ancestry. The FDA considers genetic testing “medical devices” , which means that FDA approval was necessary to market them. 23andMe failed to respond to the FDA’s concerns and, for a time, was forced to release only ancestry-related results.

Within a few years, however, the FDA and 23andMe, worked out their “misunderstandings” and approval to continue to sell the saliva-based kits was given. As of April 2017, FDA allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. This marks the first time that the FDA has allowed direct to consumer tests to be conducted with FDA approval.

The company markets their product in the US, the UK, and Canada. As of September of 2017, the company has been listed as having a value of $1.5 billion. More than 2 million kits have been sold in the US alone.

In 2015, the company made a decision to NOT supply pharmaceutical companies with raw data, but rather to pursue the development of new drugs themselves.

Company headquarters are still located in Moutain View, California.

23andMe

History

In 2015, the company made a decision to NOT supply pharmaceutical companies with raw data, but rather to pursue the development of new drugs themselves.

Company headquarters are still located in Moutain View, California.

ABIOMED Corporate Office

Abiomed, founded in 1981 originally as Applied Biomedical Corporation, designs, develops and manufactures medical implant devices, such as pacemakers and artificial hearts.

The company created the first artificial heart in 2001. Since then, the Impella heart device has received numerous FDA approvals for its use. In addition to the heart pump, the company engages in the research, development, prototyping, and the pre-serial production of a percutaneous expandable catheter pump, which enhances blood circulation from the heart. Abiomed went public on the NYSE and can be found under the ticker symbol: ABMD.

In 2016, the company reported $329.5 million in revenue, $65.1 million in operating income, $38.1 million in net income, $423 million in total assets, and $369 million in equity. Abiomed operates in the US, Canada, Europe, and Japan.

Abiomed

Abiomed, founded in 1981 originally as Applied Biomedical Corporation, designs, develops and manufactures medical implant devices, such as pacemakers and artificial hearts.